Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $52.5000 (-16.67%) ($50.0000 - $65.0000) on Mon. Jun. 25, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.69% (three month average) | RSI | 29 | Latest Price | $52.5000(-16.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -7.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -16.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -4.345% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.345% (StdDev 8.69%) | Hourly BBV | 0 () | Intraday Trend | -19.2% | | | |
|
Resistance Level | $86.5 | 5 Day Moving Average | $67.1(-21.76%) | 10 Day Moving Average | $75.87(-30.8%) | 20 Day Moving Average | $86.5(-39.31%) | To recent high | -80.6% | To recent low | 0% | Market Cap | $1.034b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |